echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > One year of effective AIDS prevention therapy with a single medication, early clinical results are positive

    One year of effective AIDS prevention therapy with a single medication, early clinical results are positive

    • Last Update: 2021-09-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today, Merck & Co.


    With the emergence of "cocktail therapy", AIDS has changed from a disease-causing disease that has become a fascinating disease to a chronic disease that can be controlled by drugs


    Islatravir is an innovative NRTTI developed by Merck.


    In this double-blind, placebo-controlled phase 1 clinical trial, 24 healthy participants implanted an implant containing different doses of islatravir in the upper arm, which can slowly release the drug in the body to achieve long-term maintenance drug treatment The effect of concentration


    The test results showed that the three different doses of implants maintained the concentration of islatravir above the level of antiviral efficacy within 12 weeks


    Note: This article is intended to introduce medical and health research, not to recommend treatment options


    Reference materials:

    [1] Merck Presents Results from Phase 1 Trial Evaluating Investigational Islatravir Subdermal Implant for the Prevention of HIV-1 Infection at CROI 2021.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.